| RS1554714095 |
PLEC
|
Health Risk |
Pathogenic |
— |
| RS1554715600 |
PLEC
|
Health Risk |
Likely pathogenic |
— |
| RS1554715907 |
PLEC
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS1554716257 |
SECISBP2
|
Health Risk |
Likely pathogenic |
— |
| RS1554716504 |
SPTLC1
|
Health Risk |
Likely pathogenic |
Neuropathy, hereditary sensory and autonomic |
| RS1554717956 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Q, Epidermolysis bullosa simplex 5B |
| RS1554718962 |
C5
|
Health Risk |
Likely pathogenic |
Complement component 5 deficiency, Complement component 5 deficiency |
| RS1554719990 |
PLEC
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2Q, Epidermolysis bullosa simplex with nail dystrophy |
| RS1554720083 |
PLEC
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of plectin, Neuromuscular disease caused by qualitative or quantitative defects of plectin |
| RS1554721033 |
NR5A1
|
Health Risk |
Likely pathogenic |
— |
| RS1554721227 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1554721235 |
NR5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
46, XY sex reversal 3 |
| RS1554721492 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex with nail dystrophy, Epidermolysis bullosa simplex with nail dystrophy |
| RS1554721745 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Q, Epidermolysis bullosa simplex with nail dystrophy |
| RS1554721879 |
LMX1B
|
Health Risk |
Pathogenic |
Nail-patella syndrome, Nail-patella syndrome |
| RS1554721883 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS1554721897 |
LMX1B
|
Health Risk |
Likely pathogenic |
— |
| RS1554722232 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS1554722453 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS1554723160 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS1554723625 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS1554724125 |
PLEC
|
Health Risk |
Pathogenic |
— |
| RS1554724691 |
GFI1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554724694 |
GFI1B
|
Health Risk |
Pathogenic |
Platelet-type bleeding disorder 17, Platelet-type bleeding disorder 17 |
| RS1554725033 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS1554725034 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia, Citrullinemia type I |
| RS1554725677 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia type I, Citrullinemia |
| RS1554725724 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia type I, Citrullinemia |
| RS1554725979 |
GLE1
|
Health Risk |
Likely pathogenic |
— |
| RS1554726245 |
COL5A1
|
Health Risk |
Likely pathogenic |
Hyperextensible skin, Cigarette-paper scars |
| RS1554726251 |
COL5A1
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1554726279 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1554726283 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1554727954 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 5, NOTCH1-related disorder |
| RS1554728327 |
IARS1
|
Health Risk |
Pathogenic |
Growth retardation, intellectual developmental disorder |
| RS1554728351 |
CDK5RAP2
|
Health Risk |
Pathogenic |
Microcephaly 3, primary |
| RS1554728424 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1554728428 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1554728529 |
NOTCH1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554728698 |
LMX1B
|
Health Risk |
Pathogenic |
Nail-patella syndrome, Inborn genetic diseases |
| RS1554729113 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1554729118 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1554729443 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1554730137 |
CDK5RAP2
|
Health Risk |
Pathogenic |
Microcephaly 3, primary |
| RS1554730184 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1554730670 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Neoplasm |
| RS1554730737 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Aortic valve disease 1 |
| RS1554730749 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1554730758 |
NOTCH1
|
Health Risk |
Likely pathogenic |
— |
| RS1554731002 |
TMC1
|
Health Risk |
Pathogenic |
— |
| RS1554732594 |
TRIM32
|
Health Risk |
Likely pathogenic |
— |
| RS1554732623 |
TRIM32
|
Health Risk |
Pathogenic/Likely pathogenic |
TRIM32-related disorder, TRIM32-related disorder |
| RS1554733019 |
TRIM32
|
Health Risk |
Pathogenic |
— |
| RS1554737064 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1554737534 |
CACNA1B
|
Health Risk |
Pathogenic |
— |
| RS1554738159 |
CACNA1B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements |
| RS1554738360 |
TUBB8
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 2, Oocyte maturation defect 2 |
| RS1554741638 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1554743428 |
TDRD7
|
Health Risk |
Pathogenic |
Cataract 36, Cataract 36 |
| RS1554744860 |
TDRD7
|
Health Risk |
Pathogenic |
Cataract 36, Cataract 36 |
| RS1554745695 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS1554746094 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS1554746097 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1554746116 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1554746442 |
SPTAN1
|
Health Risk |
Likely pathogenic |
— |
| RS1554746565 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1554746793 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1554746855 |
ANKS6
|
Health Risk |
Pathogenic |
— |
| RS1554747007 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1554747871 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1554747933 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1554748292 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS1554748528 |
GRHPR
|
Health Risk |
Pathogenic |
Primary hyperoxaluria, type II |
| RS1554748534 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1554748574 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1554748598 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1554749639 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1554749672 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1554752310 |
CACNA1B
|
Health Risk |
Pathogenic |
— |
| RS1554752805 |
FKTN
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS1554752857 |
PRDM12
|
Health Risk |
Likely pathogenic |
— |
| RS1554752862 |
FKTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability) |
| RS1554753226 |
LRSAM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS1554753528 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1554753670 |
LRSAM1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS1554754007 |
ROR2
|
Health Risk |
Pathogenic |
— |
| RS1554754182 |
FKTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS1554754342 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS1554754678 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS1554755313 |
CDK5RAP2
|
Health Risk |
Likely pathogenic |
— |
| RS1554756035 |
SYNE1
|
Health Risk |
Pathogenic |
— |
| RS1554756114 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1554757211 |
MUSK
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS1554757237 |
MUSK
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 1, Fetal akinesia deformation sequence 1 |
| RS1554757924 |
OPLAH
|
Health Risk |
Likely pathogenic |
OPLAH-related disorder, OPLAH-related disorder |
| RS1554758408 |
CACNA1B
|
Health Risk |
Pathogenic |
— |
| RS1554759745 |
SPTAN1
|
Health Risk |
Pathogenic |
Self-limited epilepsy with centrotemporal spikes, Self-limited epilepsy with centrotemporal spikes |
| RS1554759918 |
OPLAH
|
Health Risk |
Likely pathogenic |
5-Oxoprolinase deficiency, 5-Oxoprolinase deficiency |
| RS1554760412 |
OPLAH
|
Health Risk |
Pathogenic |
5-Oxoprolinase deficiency, 5-Oxoprolinase deficiency |
| RS1554760445 |
ABO
|
Health Risk |
association |
ABO blood group system, ABO blood group system |